medilawindia

Delhi, India Founded: 2021 • Age: 5 yrs
Provides drug licensing and regulatory support services for the pharmaceutical industry.
Annual revenue $93,118 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About medilawindia

medilawindia is a company based in Delhi (India) founded in 2021. It operates as a B2B. medilawindia operates in a competitive market with competitors including ProPharma Group, Validant, PharmaLex, Technical Safety Services and Celegence, among others.

  • Headquarter Delhi, India
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Elt Corporate Private Limited
  • Date of Incorporation 05 Jul, 2019
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $93.12 K (USD)
    17212.71
    as on Mar 31, 2021
  • Net Profit
    $920.24 (USD)
    124.29
    as on Mar 31, 2021
  • EBITDA
    $10.22 K (USD)
    611.67
    as on Mar 31, 2021
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of medilawindia

Premium access

Detailed funding history for medilawindia

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by medilawindia

Investments
Premium access

Investment portfolio details for medilawindia

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - medilawindia

Premium access

Detailed financials for medilawindia

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Medilawindia Comparisons

medilawindia Primary company
Description
Provides drug licensing and regulatory support services for ...
Location
Delhi, India
Founded Year
2021
Annual Revenue
$93.12 K (USD)
Net Profit
$920.24 (USD)
EBITDA
$10.22 K (USD)
Employees
Not available
Premium access

Peer comparison for medilawindia

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of medilawindia

medilawindia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ProPharma Group, Validant, PharmaLex, Technical Safety Services and Celegence, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device
Locked Locked Locked
Regulatory, compliance, and quality consulting for GxP lifecycles is provided.
Locked Locked Locked
CRO specializing in regulatory affairs and pharmacovigilance
Locked Locked Locked
Healthcare instrumentation, medical gas systems, and related devices are manufactured.
Locked Locked Locked
Regulatory consulting and solutions for pharmaceuticals and medical devices compliance.
Locked Locked Locked
Provides radiopharmaceutical equipment, synthesis solutions, and custom services for labs.
Premium access

Detailed competitors of medilawindia

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Medilawindia

Premium access

Complete news archive for medilawindia

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about medilawindia

medilawindia was founded in 2021.

medilawindia is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Annual revenue of medilawindia is $93.12K as on Mar 31, 2021.

medilawindia, established in 2021 and currently in Dissolved stage, focuses on providing healthcare solutions, producing pharmaceutical products, regulatory services, and drug licensing. Provides drug licensing and regulatory support services for the pharmaceutical industry. Adapting to market demands with innovation and client-focused strategies.

medilawindia's top competitors include ProPharma Group, PharmaLex and Pharma-Bio Serv.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available